Korro Bio Inc expected to post a loss of $2.58 a share - Earnings Preview

Korro Bio

09/05/2025 12:01

Korro Bio Inc KRRO.OQ KRRO.O is expected to show a rise in quarterly revenue when it reports  results  for the period ending June 30 2025

The Cambridge Massachusetts-based  company is expected to report revenue of $482.33 thousand, according to the mean estimate from 6 analysts, based on LSEG data.

‚ÄãLSEG's mean analyst estimate for Korro Bio Inc is for a loss of $2.58 per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 10 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts had fallen by about 1.7% in the last three months. ‚Äã

Wall Street's median 12-month price target for Korro Bio Inc is $95.00‚Äã, above‚Äã its last closing price of $15.40. ‚Äã‚Äã‚Äã

Previous quarterly performance (using preferred earnings measure in US dollars). ‚Äã

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2025
-2.55
-2.60
-2.49
Beat
4.4
Dec. 31 2025
-2.00
-2.48
-2.26
Beat
8.9
Sep. 30 2024
-2.60
-2.61
-2.26
Beat
13.4‚Äã
Jun. 30 2024
-2.40
-2.39
-2.43
Missed
-1.5
‚Äã‚ÄãMar. 31 2024
-2.49
-2.51
-2.44
Beat
2.8
Dec. 31 2023
-2.57
-2.36
-25.65
Missed
-985.3‚Äã
Sep. 30 2023
-16.50
-17.72
-15.50
Beat
12.6
Jun. 30 2023
-17.34
-17.76
-15.00
Beat
15.6

This summary was machine generated May 9 at 11:01 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)